136 related articles for article (PubMed ID: 7833476)
1. Fibrinogen inhibits the heparin cofactor II-mediated antithrombin activity of dermatan sulfate.
Zammit A; Dawes J
Blood; 1995 Feb; 85(3):720-6. PubMed ID: 7833476
[TBL] [Abstract][Full Text] [Related]
2. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.
Okwusidi JI; Anvari N; Kulczycky M; Blajchman MA; Buchanan MR; Ofosu FA
J Lab Clin Med; 1991 May; 117(5):359-64. PubMed ID: 2019790
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of thrombin inhibition by heparin cofactor II and antithrombin in the presence of the ray (Raja radula) skin dermatan sulfate.
Ben Mansour M; Dhahri M; Vénisse L; Jandrot-Perrus M; Chaubet F; Maaroufi RM
Thromb Res; 2009 Apr; 123(6):902-8. PubMed ID: 19046760
[TBL] [Abstract][Full Text] [Related]
4. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III.
Koyama T; Parkinson JF; Sié P; Bang NU; Müller-Berghaus G; Preissner KT
Eur J Biochem; 1991 Jun; 198(3):563-70. PubMed ID: 1646716
[TBL] [Abstract][Full Text] [Related]
5. Effect of oligodeoxynucleotide thrombin aptamer on thrombin inhibition by heparin cofactor II and antithrombin.
Holland CA; Henry AT; Whinna HC; Church FC
FEBS Lett; 2000 Nov; 484(2):87-91. PubMed ID: 11068038
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonist.
Buchanan MR; Brister SJ
Thromb Res; 2000 Sep; 99(6):603-12. PubMed ID: 10974347
[TBL] [Abstract][Full Text] [Related]
7. Modulation of heparin cofactor II activity by histidine-rich glycoprotein and platelet factor 4.
Tollefsen DM; Pestka CA
J Clin Invest; 1985 Feb; 75(2):496-501. PubMed ID: 3838317
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor ii in the presence of dermatan sulfate but not heparin.
Liaw PC; Becker DL; Stafford AR; Fredenburgh JC; Weitz JI
J Biol Chem; 2001 Jun; 276(24):20959-65. PubMed ID: 11294849
[TBL] [Abstract][Full Text] [Related]
9. Interaction between histidine-rich glycoprotein and platelet factor 4 with dermatan sulfate and low-molecular-weight dermatan sulfate.
Cella G; Boeri G; Saggiorato G; Paolini R; Luzzatto G; Terribile VI
Angiology; 1992 Jan; 43(1):59-62. PubMed ID: 1554154
[TBL] [Abstract][Full Text] [Related]
10. Antithrombin activity and disaccharide composition of dermatan sulfate from different bovine tissues.
Osborne SA; Daniel RA; Desilva K; Seymour RB
Glycobiology; 2008 Mar; 18(3):225-34. PubMed ID: 18156656
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice.
Vicente CP; He L; Pavão MS; Tollefsen DM
Blood; 2004 Dec; 104(13):3965-70. PubMed ID: 15315969
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
[TBL] [Abstract][Full Text] [Related]
13. Isolation of dermatan sulfate with high heparin cofactor II-mediated thrombin-inhibitory activity from porcine spleen.
Munakata H; Hsu CC; Kodama C; Aikawa J; Sakurada M; Ototani N; Isemura M; Yosizawa Z; Hayashi N
Biochim Biophys Acta; 1987 Sep; 925(3):325-31. PubMed ID: 3620505
[TBL] [Abstract][Full Text] [Related]
14. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
Scully MF; Ellis V; Seno N; Kakkar VV
Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
[TBL] [Abstract][Full Text] [Related]
15. Activation of heparin cofactor II by dermatan sulfate.
Tollefsen DM; Pestka CA; Monafo WJ
J Biol Chem; 1983 Jun; 258(11):6713-6. PubMed ID: 6687888
[TBL] [Abstract][Full Text] [Related]
16. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA
Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356
[TBL] [Abstract][Full Text] [Related]
17. Covalent heparin cofactor II-heparin and heparin cofactor II-dermatan sulfate complexes. Characterization of novel anticoagulants.
Monagle P; Berry L; O'Brodovich H; Andrew M; Chan A
J Biol Chem; 1998 Dec; 273(50):33566-71. PubMed ID: 9837939
[TBL] [Abstract][Full Text] [Related]
18. Substitution of arginine for Leu444 in the reactive site of heparin cofactor II enhances the rate of thrombin inhibition.
Derechin VM; Blinder MA; Tollefsen DM
J Biol Chem; 1990 Apr; 265(10):5623-8. PubMed ID: 2138609
[TBL] [Abstract][Full Text] [Related]
19. Heparin cofactor II inhibits thrombin-stimulated release of tissue plasminogen activator from cultured human endothelial cells in the presence of dermatan sulfate.
Kaji T; Ejiri N; Hayakawa Y; Hayashi T; Sakuragawa N
Thromb Res; 1990 Jul; 59(2):269-77. PubMed ID: 2122537
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulant activity of a dermatan sulfate from the skin of the shark Scyliorhinus canicula.
Dhahri M; Mansour MB; Bertholon I; Ollivier V; Boughattas NA; Hassine M; Jandrot-Perrus M; Chaubet F; Maaroufi RM
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):547-57. PubMed ID: 20581662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
